Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 43Genitourinary 24Thoracic 19Gynecologic 12Lymphoid 10Breast 8Head & Neck 4Dermatologic 3Tumor-Agnostic 2Sarcoma 2Other solid neoplasm 2Other hematologic neoplasm 2CNS 1

Conditions

Melanoma 3Urologic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Osteosarcoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

Nivolumab 24pembrolizumab 21Specimen Handling 17Ipilimumab 16Magnetic Resonance Spectroscopy 11CTLA-4 Antigen 8Opdualag 6Cyclophosphamide 6Biopsy 6trametinib 5relatlimab 5binimetinib 5fludarabine phosphate 4fludarabine 4dabrafenib 4cemiplimab 4atezolizumab 4X-Rays 4Paclitaxel 4Immunoglobulin G 4Disulfides 4Temozolomide 3Standard of Care 3Introns 3Interferon alpha-2 3Gemcitabine 3Carboplatin 3Blood Specimen Collection 3ulixertinib 2sargramostim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Gemcitabine × Dermatologic × 30 days × Clear all
NCT04083599 2026-06-02

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Genmab

Phase 1/2 Active not recruiting
350 enrolled
DermatologicGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Colorectal Neoplasms

NCT07492680 2026-05-29

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Bristol-Myers Squibb

Phase 2 Not yet recruiting
260 enrolled
CNSDermatologicGastrointestinal

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

NCT03093909 2026-05-20

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

M.D. Anderson Cancer Center

Phase 1 Recruiting
44 enrolled
DermatologicGenitourinarySarcoma

Bone Neoplasms, Melanoma, Osteosarcoma, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡